Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THAP domain-containing protein 3 (THAP3) is a protein in humans encoded by the THAP3 gene. The defining THAP domain is a zinc-dependent, sequence-specific DNA-binding motif of the C2CH-type zinc finger superfamily, typically located at the N-terminus. THAP3 is structurally similar to other family members (such as THAP1), predicted to participate in DNA binding and regulate transcription by RNA polymerase II through complex formation with other nuclear factors (THAP1/THAP3-HCFC1-OGT complex). Although the detailed cellular function of THAP3 remains incompletely characterized, the broader THAP protein family is implicated in cell proliferation, apoptosis, chromosome segregation, chromatin modification, and gene expression regulation. Disease associations include chromosomal abnormalities and neurological disorders, but direct mechanistic links for THAP3 have not been fully elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THAP domain-containing protein 3 (THAP3).